titlesubmit dateissue date
Now showing items 1-6 of 6
Characterization of broadly neutralizing antibody responses to HIV-1 in a cohort of long term non-progressors
Comparative Evaluation of Indirect Immunofluorescence and NS-1-Based ELISA to Determine Zika Virus-Specific IgM
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
HIV-1 Dual Infected LTNP-EC Patients Developed an Unexpected Antibody Cross-Neutralizing Activity
International network for comparison of HIV neutralization assays: the NeutNet report
Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions.